Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine

Clinical Nephrology

Volumn 49, Issue 4, 1998, Pages 232-235

  Ducloux, D ^a   Fournier, V ^a   Rebibou, J M ^a   Bresson Vautrin, C ^a   Gibey, R ^a   Chalopin, J M ^a  

^a HÔPITAL SAINT JACQUES   (France)

Author keywords

Cyclosporine; Homocysteine; Renal transplantation

Indexed keywords

COBALAMIN; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; FOLIC ACID; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHYLATION; SEX DIFFERENCE;

ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CREATININE; CYCLOSPORINE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN B 12;

EID: 0031919033     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Arnadottir M, Brattstrom L, Simonsen O, Thysell H, Hultberg B, Andersson A, Nilsson-Ehle P 1993 The effect of high-dose pyridoxine and folie acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 40: 236-240
2. Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H 1996 Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 61: 509-512
3. Brattstrom LE, Israelsson R, Jeppsson JO, Hultberg B 1988 Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 48: 215-221
4. Chauveau P, Chadefaux B, Coudé M et al. 1993 Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43 (Suppl 41): S72-S77
5. Clarke R, Daly Leslie, Robinson K et al. 1991 Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155
6. Hultberg B, Andersson A, Sterner G 1993 Plasma homocysteine in renal failure. Clin Nephrol 40: 230-235
7. Massy ZA, Chadefaux-Vekemans B, Chevalier A 1994 Hyperhomocysteinemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 9: 1103
8. Mudd SH, Levy HL, Skovby F 1989 Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Volle D (eds). The Metabolic Basis of Inherited Disease (6th edn). New York, McGraw-Hill, pp 693-774
9. Selhub J, Jacques P, Bostom A et al. 1995 Association between homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332: 286-291
10. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J 1988 Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81: 466-474
11. Ueland PM, Refsum H 1989 Plasma homocysteine, a risk factor for vascular disease. Plasma levels in health, disease, and drug therapy. J Lab Clin Med 114: 473-500
12. Wilcken DEL, Dudman NPB, Tyrell PA, Robertson MR 1988 Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 37: 697-701